PYRIMETHAMINE MARKET ANALYSIS

Pyrimethamine Market, By Dosage Form (Tablets and Capsules), By Strength (25 mg, 50 mg, 75 mg, and Others), By Indication (Malaria, Toxoplasmosis, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

On August 23, 2024, Swiss Pharma Nigeria Limited, a Nigeria-based pharmaceutical manufacturer, announced that it had received prequalification from the World Health Organization (WHO) for its sulfadoxine-pyrimethamine (SP) drug, which is utilized to prevent malaria infections in pregnant women.
In March 2020, Reddy’s Laboratories Ltd. announced the launch of Pyrimethamine Tablets USP, 25 mg, which serves as a therapeutic equivalent and the first generic version of Daraprim (pyrimethamine) Tablets. Pyrimethamine is indicated for treating toxoplasmosis when used in conjunction with a sulfonamide